TY -的T1 rifapentine-based r的耐受性egimens in latent tuberculosis infection treatment in the elderly JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.02396-2018 VL - 53 IS - 3 SP - 1802396 AU - Chan, Pei-Chun AU - Lee, Pin-Hui AU - Lu, Min-Ju AU - Huang, You-Chieh AU - Feng, Teng-Yi AU - Chen, Wen-Wen AU - Lee, Chia-Chi AU - Huang, Yen-Fang AU - Chiang, Chen-Yuan Y1 - 2019/03/01 UR - //www.qdcxjkg.com/content/53/3/1802396.abstract N2 - Management of latent tuberculosis infection (LTBI) is a core intervention in the pursuit of tuberculosis (TB) elimination and is one of the eight activities recommended by the World Health Organization [1]. We read with great interest the paper by Gao et al. [2] investigating two short-course regimens with rifapentine plus isoniazid for the treatment of LTBI in Chinese patients aged 50–70 years. They reported that due to the ever-increasing occurrence of adverse events, the 3-month once-weekly regimen and the 2-month twice-weekly regimen were truncated to 8 and 6 weeks, respectively. Gao et al. [2] concluded that the short regimens tested must be used with caution among the elderly because of a high frequency of adverse events. The findings reported by Gao et al. [2] were not consistent with our experience in Taiwan.Our experience has shown that with proper support and medical care under programmatic conditions, it is feasible to achieve a high completion rate of 3HP even among the elderly http://ow.ly/o3ED30nQfRx ER -